|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Strand MS, Lockhart AC and Fields RC:
Genetics of gastric cancer. Surg Clin North Am. 97:345–370. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hamashima C: Current issues and future
perspectives of gastric cancer screening. World J Gastroenterol.
20:13767–13774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zong L, Abe M, Seto Y and Ji J: The
challenge of screening for early gastric cancer in China. Lancet.
388:26062016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roder DM: The epidemiology of gastric
cancer. Gastric Cancer. 5 (Suppl 1):S5–S11. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ang TL and Fock KM: Clinical epidemiology
of gastric cancer. Singapore Med J. 55:621–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kuo YT, Chang TT, Muo CH, Wu MY, Sun MF,
Yeh CC and Yen HR: Use of complementary traditional Chinese
medicines by adult cancer patients in Taiwan: A nationwide
population-based study. Integr Cancer Ther. 17:531–541. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Singh N, Bansal Y, Bhandari R, Marwaha L,
Singh R, Chopra K and Kuhad A: Naringin reverses neurobehavioral
and biochemical alterations in intracerebroventricular
collagenase-induced intracerebral hemorrhage in rats. Pharmacology.
100:172–187. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen R, Qi QL, Wang MT and Li QY:
Therapeutic potential of naringin: An overview. Pharm Biol.
54:3203–3210. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bharti S, Rani N, Krishnamurthy B and Arya
DS: Preclinical evidence for the pharmacological actions of
naringin: A review. Planta Med. 80:437–451. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jeon SM, Bok SH, Jang MK, Kim YH, Nam KT,
Jeong TS, Park YB and Choi MS: Comparison of antioxidant effects of
naringin and probucol in cholesterol-fed rabbits. Clin Chim Acta.
317:181–190. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jagetia GC and Reddy TK: Modulation of
radiation-induced alteration in the antioxidant status of mice by
naringin. Life Sci. 77:780–794. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rajadurai M and Stanely Mainzen Prince P:
Preventive effect of naringin on lipid peroxides and antioxidants
in isoproterenol-induced cardiotoxicity in Wistar rats: Biochemical
and histopathological evidences. Toxicology. 228:259–268. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng H, Jiang X, Zhang Q, Ma J, Cheng R,
Yong H, Shi H, Zhou X, Ge L and Gao G: Naringin inhibits colorectal
cancer cell growth by repressing the PI3K/AKT/mTOR signaling
pathway. Exp Ther Med. 19:3798–3804. 2020.PubMed/NCBI
|
|
16
|
Ramesh E and Alshatwi AA: Naringin induces
death receptor and mitochondria-mediated apoptosis in human
cervical cancer (SiHa) cells. Food Chem Toxicol. 51:97–105. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai L, Wu H, Tu C, Wen X and Zhou B:
Naringin inhibits ovarian tumor growth by promoting apoptosis: An
in vivo study. Oncol Lett. 16:59–64. 2018.PubMed/NCBI
|
|
18
|
Banjerdpongchai R, Wudtiwai B and Khawon
P: Induction of human hepatocellular carcinoma HepG2 cell apoptosis
by naringin. Asian Pac J Cancer Prev. 17:3289–3294. 2016.PubMed/NCBI
|
|
19
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ilghami R, Barzegari A, Mashayekhi MR,
Letourneur D, Crepin M and Pavon-Djavid G: The conundrum of dietary
antioxidants in cancer chemotherapy. Nutr Rev. 78:65–76. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McDermott JH: Antioxidant nutrients:
Current dietary recommendations and research update. J Am Pharm
Assoc (Wash). 40:785–799. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nijveldt RJ, van Nood E, van Hoorn DE,
Boelens PG, van Norren K and van Leeuwen PA: Flavonoids: A review
of probable mechanisms of action and potential applications. Am J
Clin Nutr. 74:418–425. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Courdavault V, O'Connor SE, Oudin A,
Besseau S and Papon N: Towards the microbial production of
plant-derived anticancer drugs. Trends Cancer. 6:444–448. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang X, Ouyang Y, Liu J, Zhu M, Zhao G,
Bao W and Hu FB: Fruit and vegetable consumption and mortality from
all causes, cardiovascular disease, and cancer: Systematic review
and dose-response meta-analysis of prospective cohort studies. BMJ.
349:g44902014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Alam MA, Subhan N, Rahman MM, Uddin SJ,
Reza HM and Sarker SD: Effect of citrus flavonoids, naringin and
naringenin, on metabolic syndrome and their mechanisms of action.
Adv Nutr. 5:404–417. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mani JS, Johnson JB, Hosking H, Ashwath N,
Walsh KB, Neilsen PM, Broszczak DA and Naiker M: Antioxidative and
therapeutic potential of selected Australian plants: A review. J
Ethnopharmacol. 268:1135802021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blankson H, Grotterød EM and Seglen PO:
Prevention of toxin-induced cytoskeletal disruption and apoptotic
liver cell death by the grapefruit flavonoid, naringin. Cell Death
Differ. 7:739–746. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kawaguchi K, Kikuchi S, Hasegawa H,
Maruyama H, Morita H and Kumazawa Y: Suppression of
lipopolysaccharide-induced tumor necrosis factor-release and liver
injury in mice by naringin. Eur J Pharmacol. 368:245–250. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tajaldini M, Samadi F, Khosravi A,
Ghasemnejad A and Asadi J: Protective and anticancer effects of
orange peel extract and naringin in doxorubicin treated esophageal
cancer stem cell xenograft tumor mouse model. Biomed Pharmacother.
121:1095942020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tarun EI, Kurchenko VP and Metelitsa DI:
Flavonoids as effective protectors of urease from ultrasonic
inactivation in solutions. Bioorg Khim. 32:391–398. 2006.(In
Russian). PubMed/NCBI
|
|
31
|
Liu Y, Kang X, Niu G, He S, Zhang T, Bai
Y, Li Y, Hao H, Chen C, Shou Z and Li B: Shikonin induces apoptosis
and prosurvival autophagy in human melanoma A375 cells via
ROS-mediated ER stress and p38 pathways. Artif Cells Nanomed
Biotechnol. 47:626–635. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kang X, Wang H, Li Y, Xiao Y, Zhao L,
Zhang T, Zhou S, Zhou X, Li Y, Shou Z, et al: Alantolactone induces
apoptosis through ROS-mediated AKT pathway and inhibition of
PINK1-mediated mitophagy in human HepG2 cells. Artif Cells Nanomed
Biotechnol. 47:1961–1970. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qiu C, Zhang T, Zhang W, Zhou L, Yu B,
Wang W, Yang Z, Liu Z, Zou P and Liang G: Licochalcone a inhibits
the proliferation of human lung cancer cell lines A549 and H460 by
inducing G2/M cell cycle arrest and ER stress. Int J Mol Sci.
18:17612017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kabala-Dzik A, Rzepecka-Stojko A, Kubina
R, Iriti M, Wojtyczka RD, Buszman E and Stojko J: Flavonoids,
bioactive components of propolis, exhibit cytotoxic activity and
induce cell cycle arrest and apoptosis in human breast cancer cells
MDA-MB-231 and MCF-7-a comparative study. Cell Mol Biol
(Noisy-le-grand). 64:1–10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin R, Hu X, Chen S, Shi Q and Chen H:
Naringin induces endoplasmic reticulum stress-mediated apoptosis,
inhibits β-catenin pathway and arrests cell cycle in cervical
cancer cells. Acta Biochim Pol. 67:181–188. 2020.PubMed/NCBI
|
|
36
|
Ming H, Chuang Q, Jiashi W, Bin L,
Guangbin W and Xianglu J: Naringin targets Zeb1 to suppress
osteosarcoma cell proliferation and metastasis. Aging (Albany NY).
10:4141–4151. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sang Eun H, Seong Min K, Ho Jeong L,
Vetrivel P, Venkatarame Gowda Saralamma V, Jeong Doo H, Eun Hee K,
Sang Joon L and Gon Sup K: Scutellarein induces Fas-mediated
extrinsic apoptosis and G2/M cell cycle arrest in Hep3B
hepatocellular carcinoma cells. Nutrients. 11:2632019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang Y, Xu X, Li W, Miao H, Huang S, Zhou
Y, Sun Y, Li Z, Guo Q and Zhao L: Activation of endoplasmic
reticulum stress and the extrinsic apoptotic pathway in human lung
cancer cells by the new synthetic flavonoid, LZ-205. Oncotarget.
7:87257–87270. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tavsan Z and Kayali HA: Flavonoids showed
anticancer effects on the ovarian cancer cells: Involvement of
reactive oxygen species, apoptosis, cell cycle and invasion. Biomed
Pharmacother. 116:1090042019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Porta C, Paglino C and Mosca A: Targeting
PI3K/Akt/mTOR signaling in cancer. Front Oncol. 4:642014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang J, Ren X, Zhang L, Li Y, Cheng B and
Xia J: Oridonin inhibits oral cancer growth and PI3K/Akt signaling
pathway. Biomed Pharmacother. 100:226–232. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhu ML, Zhang PM, Jiang M, Yu SW and Wang
L: Myricetin induces apoptosis and autophagy by inhibiting
PI3K/Akt/mTOR signalling in human colon cancer cells. BMC
Complement Med Ther. 20:2092020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhou J, Xia L and Zhang Y: Naringin
inhibits thyroid cancer cell proliferation and induces cell
apoptosis through repressing PI3K/AKT pathway. Pathol Res Pract.
215:1527072019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yun CW and Lee SH: The roles of autophagy
in cancer. Int J Mol Sci. 19:34662018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Towers CG, Wodetzki D and Thorburn A:
Autophagy and cancer: Modulation of cell death pathways and cancer
cell adaptations. J Cell Biol. 219:e2019090332020.PubMed/NCBI
|
|
46
|
Wei M, Wu Y, Liu H and Xie C: Genipin
induces autophagy and suppresses cell growth of oral squamous cell
carcinoma via PI3K/AKT/MTOR pathway. Drug Des Devel Ther.
14:395–405. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhou J, Jiang YY, Chen H, Wu YC and Zhang
L: Tanshinone I attenuates the malignant biological properties of
ovarian cancer by inducing apoptosis and autophagy via the
inactivation of PI3K/AKT/mTOR pathway. Cell Prolif. 53:e127392020.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Raha S, Yumnam S, Hong GE, Lee HJ,
Saralamma VV, Park HS, Heo JD, Lee SJ, Kim EH, Kim JA and Kim GS:
Naringin induces autophagy-mediated growth inhibition by
downregulating the PI3K/Akt/mTOR cascade via activation of MAPK
pathways in AGS cancer cells. Int J Oncol. 47:1061–1069. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu WJ, Ye L, Huang WF, Guo LJ, Xu ZG, Wu
HL, Yang C and Liu HF: p62 links the autophagy pathway and the
ubiqutin-proteasome system upon ubiquitinated protein degradation.
Cell Mol Biol Lett. 21:292016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang YB, Gong JL, Xing TY, Zheng SP and
Ding W: Autophagy protein p62/SQSTM1 is involved in HAMLET-induced
cell death by modulating apotosis in U87MG cells. Cell Death Dis.
4:e5502013. View Article : Google Scholar : PubMed/NCBI
|
